OrganiGram
Licensed producer of medical marijuana in canada.
Launch date
Employees
Market cap
€181m
Enterprise valuation
€127m (Public information from Sep 2024)
Share price
$1.84 OGI
Moncton New Brunswick (HQ)
Financials
Estimates*
CAD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 86.8m | 79.2m | 146m | 155m | 162m | 185m | 261m |
% growth | 5 % | (9 %) | 84 % | 7 % | 5 % | 14 % | 41 % |
EBITDA | (81.1m) | (42.9m) | (15.2m) | - | 5.0m | 14.6m | 30.5m |
% EBITDA margin | (93 %) | (54 %) | (10 %) | - | 3 % | 8 % | 12 % |
Profit | (136m) | (131m) | (14.3m) | - | (36.9m) | 1.6m | (<1m) |
% profit margin | (157 %) | (165 %) | (10 %) | - | (23 %) | 1 % | - |
EV / revenue | 3.6x | 8.7x | 1.9x | 0.9x | 1.6x | 1.4x | 1.0x |
EV / EBITDA | -3.9x | -16.1x | -18.7x | - | 51.7x | 17.6x | 8.4x |
R&D budget | 1.3m | 3.5m | 6.0m | - | - | - | - |
R&D % of revenue | 1 % | 4 % | 4 % | - | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | $5.0m | Post IPO Debt | |
N/A | CAD23.0m | Post IPO Equity | |
* | N/A | $40.3m | Post IPO Equity |
N/A | CAD57.5m | Post IPO Equity | |
* | $140m | Post IPO Debt | |
N/A | CAD69.1m | Post IPO Equity | |
* | £126m | Post IPO Equity | |
* | CAD125m | Post IPO Equity | |
* | CAD125m | Post IPO Equity | |
* | N/A | Private Placement non VC | |
Total Funding | - |
Recent News about OrganiGram
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by OrganiGram
EditACQUISITION by OrganiGram Apr 2021
ACQUISITION by OrganiGram Dec 2021